ChrysCapital to take minority stake in Linux laboratoriesLinux Laboratories has secured $70 million in equity funding from ChrysCapital and Tata Capital Healthcare Fund III. This investment involv...
In 2018, Buffalo moved 56,000 cubic yards of mud dug from its waterways to Unity Island; habitat quality rose 128.8%, and fish species doubledOnce thought to be lifeless, the Buffalo River is undergoing a remarkable transformation, showcasing the power of ecological restoration. E...
Ohio Shocking Crime: Father of 4 shot dead in ‘senseless act of violence’ at restaurant during vacation days ahead of his 40th birthday; Shooter IdentifiedA man celebrating his upcoming birthday was fatally shot at a restaurant. The victim died at the scene after suffering multiple gunshot wou...
Man jumps into historic Erie Canal to evade police pursuit and what happened next will shock you; chilling details insideA police chase came to a dramatic end when a man jumped into the Erie Canal while attempting to evade officers, with authorities now invest...
Eris Lifesciences shares in focus on move to acquire Swiss Parenterals in Rs 423 crore dealEris Lifesciences is set to fully acquire its injectable unit, Swiss Parenterals. The deal involves a share swap valued at Rs 423.3 crore. ...
Donald Trump's war against Latin American drug cartels! Nuclear submarine, missile cruiser, warships, over 2000 MarinesTrump administration designated Mexico's Sinaloa Cartel and other drug gangs as well as Venezuelan criminal group Tren de Aragua as global ...
Eris Lifesciences' unit gets Brazil health regulator nodEris Lifesciences announced that its Ahmedabad manufacturing facility secured approval from ANVISA, Brazil's health regulatory agency, foll...
Stocks in news: IndiGo, Apollo Hospitals, Hyundai, TCS, NMDC, Laurus LabsApollo Hospitals' Hyderabad-based arm Apollo Health and Lifestyle Limited (AHLL) has acquired a controlling stake in Lucknow-based Care Dia...
Buy Eris Lifesciences, target price Rs 1100: Prabhudas LilladherEris Lifesciences Ltd. key Products/Revenue Segments include Pharmaceuticals and Other Operating Revenue for the year ending 31-Mar-2023.
Neutral on Eris Lifesciences, target price Rs 930: Motilal OswalEris Lifesciences Ltd. key Products/Revenue Segments include Pharmaceuticals and Other Operating Revenue for the year ending 31-Mar-2023.
Buy Eris Lifesciences, target price Rs 1070: HDFC SecuritiesEris Lifesciences Ltd. key Products/Revenue Segments include Pharmaceuticals and Other Operating Revenue for the year ending 31-Mar-2023.
Buy Eris Lifesciences, target price Rs 1050: Prabhudas LilladherEris Lifesciences Ltd., incorporated in the year 2007, is a Mid Cap company (having a market cap of Rs 12633.84 Crore) operating in Pharmac...
Erie News Now anchor Emily Matson dies. All you should know about herAfter working as a news anchor for Erie News Now for about 20 years, Emily Matson has died at the age of 42. Know about her and what her co...
Buy Eris Lifesciences, target price Rs 825: Prabhudas LilladherEris Lifesciences Ltd., incorporated in the year 2007, is a Mid Cap company (having a market cap of Rs 9395.71 Crore) operating in Pharmace...
Market Movers: Resurgent Covid brings tailwinds for healthcare stocksShares of healthcare stocks – pharma companies and diagnostic companies – jumped in trade today as the government got into battle mode to s...
Eris Lifesciences jumps 10% as investors cheer JV with MJ BiopharmThe JV, dubbed Eris Biopharm, would be in the ratio of 70:30, with Eris holding a 70 per cent stake.
- CMI Energy lands $150 million India deal
A US-based energy firm has landed a $150 million contract to help build a new power plant in India.